(Q33841129)

English

Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.

scientific article

Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Lars Möllgård

11

object named as

Lars Möllgård

0 references

author name string

Gunnar Juliusson

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Karin Karlsson

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Vladimir Lj Lazarevic

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Anders Wahlin

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Mats Brune

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Petar Antunovic

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Asa Derolf

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Hans Hägglund

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Holger Karbach

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sören Lehmann

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lars Möllgård

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dick Stockelberg

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Helene Hallböök

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Martin Höglund

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Swedish Acute Leukemia Registry Group, the Swedish Acute Myeloid Leukemia Group, the Swedish Adult Acute Lymphoblastic Leukemia Group

15

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

8 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

117

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

4238-4246

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Treatment of adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Treatment of murine leukaemia with x-rays and homologous bone marrow: II. 1957.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Hematopoietic stem cell transplantation: a global perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Anthracycline dose intensification in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

High-dose daunorubicin in older patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Population-based analyses in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Variation in supportive care practices in hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Why are there regional differences in stem cell transplantation activity? An EBMT analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

The EBMT activity survey 2008: impact of team size, team density and new trends

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

21 January 2018

Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

7 January 2021

based on heuristic

inferred from DOI database lookup

Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based cytogenetic study of adults with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjusted conditioning for allogeneic transplantation in a single center setting: mixed chimerism heralds relapse

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26033

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.26033

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33841129&oldid=1952145043"